Views
5 years ago

Tratado de Actualización en Psiquiatría - Fascículo 25

  • Text
  • Distimia
  • Mayor
  • Depresivo
  • Premenstrual
  • Disforico
  • Atipica
  • Psicotica
  • Puerperal
  • Estacional
Trastornos del estado de ánimo - Parte 2 - Autores: Dr. Juan Cristóbal Tenconi, Dra. Oriana Sullivan Machado, Dr. Federico Nicolás Pavlovsky

Trastornos

Trastornos del estado de ánimo // Referencias bibliográficas Psychiatry, 2006. 67(12): p. e18. 232. Horwath E, et al. The validity of major depression with atypical features based on a community study. J Affect Disord, 1992. 26(2): p. 117-25. 233. Jarrett RB, et al. Treatment of atypical depression with cognitive therapy or phenelzine. Arch Gen Psychiatry, 2000. 57(11): p. 1084. 234. Derecho CN, et al. Atypical depression among psychiatric inpatients: clinical features and personality traits. J Affect Disord, 1996. 39(1): p. 55-9. 235. Marquez M. Trastornos depresivos menores y crónicos., en Depresiones. , S. Rojtemberg, Editor. 2006., Polemos: Buenos aires. p. 89-126. 236. Thase ME. Recognition and diagnosis of atypical depression. J Clin Psychiatry, 2007. 68 Suppl 8: p. 11-6. 237. Clayton PJ. Depression subtyping: treatment implications. J Clin Psychiatry, 1998. 59 Suppl 16: p. 5-12; discussion 40-2. 238. Harrison WM, et al. The tyramine challenge test as a marker for melancholia. Arch Gen Psychiatry, 1984. 41(7): p. 681-5. 239. Bruder GE, et al. Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes. J Abnorm Psychol, 1989. 98(2): p. 177-86. 240. Clark LA y Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol, 1991. 100(3): p. 316- 36. 241. Akiskal H. Subtipos clínicos de depresión crónica resistente, in Perspectivas en Psiquiatría, Wiley, Editor. 1991, Feighner, JP. Boyer WF. p. 65-82. 242. Akiskal HS, et al. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. J Affect Disord, 1983. 5(2): p. 115-28. 243. Akiskal HS. The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions. J Affect Disord, 2005. 84(2-3): p. 107-15. 244. Cervera Enguix S, et al. Depresión atípica, en Trastorno de humor 1999, Roca Benazar: Madrid. p. 443 -460. 245. Rao U, et al. Childhood depression and risk of suicide: a preliminary report of a longitudinal study. J Am Acad Child Adolesc Psychiatry, 1993. 32(1): p. 21-7. 246. Davidson JR y Thase ME. A history of the concept of atypical depression. J Clin Psychiatry, 2007. 68(2): p. e03. 247. Figert AE. Premenstrual syndrome as scientific and cultural artifact. Integr Physiol Behav Sci, 2005. 40(2): p. 102-13. 248. Pearlstein T y Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci, 2008. 33(4): p. 291-301. 249. Wang YP, et al. Dimensionality of the premenstrual syndrome: confirmatory factor analysis of premenstrual dysphoric symptoms among college students. Braz J Med Biol Res, 2007. 40(5): p. 639-47. 250. Dickerson LM, Mazyck PJ y Hunter MH. Premenstrual syndrome. Am Fam Physician, 2003. 67(8): p. 1743-52. 251. Pearlstein T y Stone AB. Premenstrual Syndrome, in Diagnostic Dilemmas I, D.A. Tomb, Editor. 1998, W. B. Saunders: Philadelphia. p. 577-590. 252. Grady-Weliky TA. Clinical practice. Premenstrual dysphoric disorder. N Engl J Med, 2003. 348(5): p. 433-8. 253. Yonkers KA, O'Brien PM y Eriksson E. Premenstrual syndrome. Lancet, 2008. 371(9619): p. 1200-10. 254. Landen M y Thase ME. A model to explain the therapeutic effects of serotonin reuptake inhibitors: the role of 5-HT2 receptors. Psychopharmacol Bull, 2006. 39(1): p. 147-66. 255. Jovanovic H, et al. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res, 2006. 148(2-3): p. 185-93. 256. Dhingra V, et al. Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder. Obstet Gynecol, 2007. 110(4): p. 788-92. 257. Inoue Y, et al. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests. Psychopharmacology (Berl), 2007. 190(2): p. 213-9. 258. Thys-Jacobs S, McMahon D y Bilezikian JP. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder. J Clin Endocrinol Metab, 2008. 93(1): p. 96-102. 259. Thys-Jacobs S, McMahon D y Bilezikian JP. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin Endocrinol Metab, 2007. 92(8): p. 2952-9. 260. Landen M, y Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety, 2003. 17(3): p. 122-9. 261. Teng CT, et al. Premenstrual dysphoric symptoms amongst Brazilian college students: factor structure and methodological appraisal. Eur Arch Psychiatry Clin Neurosci, 2005. 255(1): p. 51-6. 262. Hartlage SA, Brandenburg DL, y Kravitz HM. Premenstrual exacerbation of depressive disorders in a community-based sample in the United States. Psychosom Med, 2004. 66(5): p. 698-706. 263. Hsiao MC, Hsiao CC y Liu CY. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psychiatry Clin Neurosci, 2004. 58(2): p. 186-90. 264. Glick R, et al. Treatment of premenstrual dysphoric symptoms in depressed women. J Am Med Womens Assoc, 1991. 46(6): p. 182-5. 265. Levitte SS. Treatment of premenstrual exacerbation of schizophrenia. Psychosomatics, 1997. 38(6): p. 582-4. 266. Arango Lopez C, Crepo Facorro B y Arroyo MB. Neuroimagen estructural y funcional en los trastornos afectivos., en Neuroimágen en Psiquiatría. 2003, ARS Medica: Barcelona. 267. Vazquez G. Depresión y bipolaridad, en Trastornos del estado de ánimo. 2007, Polemos: Buenos Aires. p. 88-89). 268. Beyer JL y Krishnan KR. Volumetric brain imaging findings in mood disorders. Sciens Editorial Bipolar Disord, 2002. 4(2): p. 89-104. 269. Taylor WD, et al. Evidence of white matter tract disruption in MRI hyperintensities. Biol Psychiatry, 2001. 50(3): p. 179-83. 270. Fountoukalis K, Geramisov G. The Relationship of Regional Cerebral Blood Flow With Subtypes of Major Depression. Progress en Neuro-Psychopharmacology & Biological Psychiatry, 2004. 28: p. 537-546. 271. Vollmert C, et al. Depression and modern neuroimaging. Fortschr Neurol Psychiatr, 2004. 72(8): p. 435-45. 272. Angst J, et al. Recurrence of bipolar disorders and major depression. A lifelong perspective. Eur Arch Psychiatry Clin Neurosci, 2003. 253(5): p. 236-40. 273. Asociación Psiquiátrica de América Latina., Guía Latinoamericana de Diagnóstico Psiquiátrico (GLADP). 2004: TONOCONTINUO. 274. Versiani M y Nardi AE. Dysthymia: Clinical Picture, Comorbidity, and Outcome, en Dysthymia and the Spectrum of Chronic Depressions, Akiskal H and G.B. Cassano, Editors. 1997, Guilford: N.Y. p. 35 - 43. 275. Akiskal HS. Over view of Chronic Depressions and Theri Clinical Management, in Dysthymia and the Spectrum of Chronic Depressions, Akiskal H and G.B. Cassano, Editors. 1997, Guilford: N.Y. p. 1 -35. 276. Akiskal HS. Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin. J Affect Disord, 2001. 62(1-2): p. 17-31. 277. Rhebergen D, et al. The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. J Affect Disord, 2008. 278. National Library of Medicine. Medical Subject Headings thesaurus. (Web Page) 2008; Available from: http://www.nlm.nih.gov/mesh. 279. Cassano GB, et al. Conceptual underpinnings and empirical support for the mood spectrum. Psychiatr Clin North Am, 2002. 25(4): p. 699-712, v. 280. Akiskal HS, et al. The nosological status of neurotic depression: a prospective three- to four-year follow-up examination in light of the primary-secondary and unipolar-bipolar dichotomies. Arch Gen Psychiatry, 1978. 35(6): p. 756-66. 281. Merikangas KR, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry, 2007. 64(5): p. 543-52. 282. Carlson GA y Goodwin FK. The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry, 1973. 28(2): p. 221-8. 283. Benazzi F. Bipolar II disorder: epidemiology, diagnosis and management. CNS Drugs, 2007. 21(9): p. 727-40. 284. Akiskal HS y Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull, 1987. 23(1): p. 68-73. 285. Akiskal HS. et al. Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study. J Affect Disord, 2005. 85(1-2): p. 29-36. 286. Tondo L y Baldessarini RJ. Reduced suicide risk during lithium maintenance treatment. J Clin Psychiatry, 2000. 61 Suppl 9: p. 97-104. 287. Baca-Garcia E, et al. Diagnostic stability and evolution of bipolar disorder in clinical practice: a prospective cohort study. Acta Psychiatr Scand, 2007. 115(6): p. 473-80. 288. Frans EM, et al. Advancing paternal age and bipolar disorder. Arch Gen Psychiatry, 2008. 65(9): p. 1034-40. 289. Robinson LJ y Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord, 2006. 8(2): p. 103-16. 290. Roy-Byrne P, et al. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl, 1985. 317: p. 1-34. 291. Angst J y Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry, 2000. 48(6): p. 445-57. 292. Baldessarini RJ, et al. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. Bipolar Disord, 2007. 9(4): p. 386- 93. 293. Baldessarini RJ, et al. Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. Bipolar Disord, 1999. 1(2): p. 91- 7. 294. Post RM, et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord, 2003. 5(6): p. 396-406. 295. Daban C, et al. Clinical correlates of first-episode polarity in bipolar disorder. Compr Psychiatry, 2006. 47(6): p. 433-7. 296. Perugi G, et al. Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry, 2000. 41(1): p. 13-8. 297. Judd LL, et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord, 2003. 73(1-2): p. 19-32. 298. Post RM, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord, 2003. 5(5): p. 310-9. 299. Altshuler LL, et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry, 2006. 67(10): p. 1551-60. 300. Sachs GS. Reducing Diagnostic Error: Recognition of Bipolar Depression Phenomenology, in Understanding Bipolar Disorders. 2008: Washington. p. 1-7. 301. Hoffman RE, Stopek S y Andreasen NC. Thought disorder specificity in functional psychoses, in Controversies in Schizophrenia: Changes and Constancies, M. Alpert, Editor. 1985, Guilford, : New York,. p. 432 pages. 302. Freud S. Inhibición, síntoma y angustia, en Obras completas, Editor. 2003, Amorrortu editores: Bs. As. p. 71-161. 303. Baranger WYM. La situación analítica como campo dinámico, en Problemas Tratado de Actualización en Psiquiatría 31

CAPÍTULO VII Trastornos del estado de ánimo // Referencias bibliográficas del campo analítico. 1992, Kargieman: Buenos Aires. 304. Tenconi JC. Entrevista psiquiátrica, en Tratado de actualización en Psiquiatría, J.C. Tenconi, Editor. 2006, Sciens: Buenos Aires. 305. Kay J. Integrated Treatment of Psyciatric Disorders. Review of Psychiatry, ed. John M. Oldham and M.B. Riba. Vol. 20. 2001, Washington: American Psychiatric Press. 306. Leichsenring F y Rabung S. Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA, 2008. 300(13): p. 1551-65. 307. Rush AJ, et al. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry, 2008. 65(8): p. 870-80. 308. Contreras J, et al. The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatr Scand, 2008. 309. Gerretsen P y Pollock BG. Pharmacogenetics and the serotonin transporter in late-life depression. Expert Opin Drug Metab Toxicol, 2008. 4(12): p. 1465-1478. 310. Perlis RH, et al. Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder. Biol Psychiatry, 2008. 311. McAlpine DE, et al. Cytochrome P450 2D6 genotype variation and venlafaxine dosage. Mayo Clin Proc, 2007. 82(9): p. 1065-8. 312. Brown W. Treatment Response in Melancholia. Acta Psychiatr Scand, 2007. 115: p. 125-129. 313. Madsen T. Electroconvulsive Therapy in Melancholia: The Rol of Hippocampal Neurogenesis. Acta Psychiatr Scand, 2007. 115: p. 130-135. 314. Joyce P, Luty J, Rae A. A Differential Response to Nortriptiline and fluexetine in Melancholic Depression: The importance of Age and Gender. Acta Psychiatr Scand, 2003. 108: p. 20-23. 315. Golden RN, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry, 2005. 162(4): p. 656-62. 316. Michael T. Bright Light Therapy: Side Effects and Benefits Across the Symptom Spectrum. J Clin Psychiatry, 1999. 60: p. 799-808. 317. Lam RW, et al. Effects of light therapy on suicidal ideation in patients with winter depression. J Clin Psychiatry, 2000. 61(1): p. 30-2. 318. Eastman CI, et al. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry, 1998. 55(10): p. 883-9. 319. MacKenzie, B y Levitan RD. Psychic and somatic anxiety differentially predict response to light therapy in women with seasonal affective disorder. J Affect Disord, 2005. 88(2): p. 163-6. 320. Reichborn-Kjennerud T y Lingjaerde O. Response to light therapy in seasonal affective disorder: personality disorders and temperament as predictors of outcome. J Affect Disord, 1996. 41(2): p. 101-10. 321. Lam R, L.A. Canadian consensus guidelines for the treatment of seasonal affective disorder. 2002 (cited 2007). 322. Kogan A, G.P..Side Effects of Short Term 10.000 Lux Light Therapy. Am J Psychiatry, 1998. 155: p. 293-294. 323. Labbate LA, et al. Side effects induced by bright light treatment for seasonal affective disorder. J Clin Psychiatry, 1994. 55(5): p. 189-91. 324. Chan PK, L.R., Perry KF. Mania precipitades by light therapy for patients with SAD. J Clin Psychiatry, 1994. 54: p. 454. 325. Oren DA, W.K., Spinelli M, Epperson CN, et al. An open trial of morning ligth therapy for treatment of antepartum depression. Am J Psychiatry, 2002. 159: p. 666-669. 326. Ruhrman S, H.K., Hoflich M. Effects of Fluoxetine versus Bbright licght in the treatment of seasonal affective disorder. Psychological Medicine, 1993. 28: p. 923- 933. 327. Moscovitch A, Eagles J. A Placebo controlled study of sertraline in the treatment of outpatient with seasonal affective disorder. Psychophamacology, 2004. 171: p. 390-397. 328. Yonkers K, Howello H. Pharmacological Treatment of Postpartum Women with Onset Major Depressive Disorder: A Randomized Controlled Trail with Paroxetine. J Clin Psychiatry, 2008. 68: p. 659-665. 329. Corral M, Zhang HB. Morning Light Therapy for Postpartum Depression. Arch Womens Ment Health, 2007. 10: p. 221-224. 330. Tyrka A, Mello M, Carpenter L. Psychotic Major Depression. A Benefit-Risk Assesment of Treatment Options. Drug Safety, 2006. 29: p. 491-508. 331. Xeniditis K, C.C., Drug Treatment For Psychotic Depression. British Journal of Psychiatry, 2006. 189: p. 383-385. 332. Birkenhager T, Lucius S. ECT Response in Delusional versus Non Delusional Depressed inpatient. Journal of Affective Disorders, 2003. 74: p. 191-195. 333. Fink M. Convulsive Therapy: A Review of the First 55 years. Journal of Affective Disorders, 2001. 63: p. 1-15. 334. Wijkstra J, L.J., Balk F, Geddes J. Pharmacological Treatment For Unipolar Psychotic Depression.British Journal of Psychiatry 2006. 188: p. 410-415. 335. Serretti A, L.E., Zanardi R, et al. Patterns of symptom improvement during antidepressant treatment of delusional depresion. Psychiatry Research 2000. 99: p. 185-190. 336. Zanardi R, F.L., Serreti A. Venalafaxine Versus Fluvoxamine in the Treatment of Delusional Depression: a Pilot Double Study. J Clin Psychiatry 2000. 61: p. 15- 20. 337. Carrasco JL, S.C. Clinical Effects of Pharmacological Variations in Selective Reuptake Inhibitors: An Overview. Int J Clin Pract, 2005. 59: p. 1428-1434. 338. Zanardi A, F.L. Gasperini et al., Faster Onset of action of Fluvoxamine in combination with Pindolol in the Treatment of Delusional Depression: A Controlled Study. Journal of Clinical Psychopharmacology, 1998. 18: p. 441-446. 339. Rothschild A, P.K. Selective Serotonin Reuptake inhibitors and delusional Depression. Am J Psychiatry 1999. 156: p.6. 340. Konstantiniditis A, Nirnberger G, et al. Quetiapine in combination with citalopran in patient with unipolar psychotic depression. Progress in Neuro- Psychopharmacology & Biological Psychiatry, 2007. 31: p. 242-247. 341. Konig F, Petersdorff T. First Experiences in Combination Therapy Using Olanzapine With SSRI (citalopram, paroxetine) in Delusional Depression. Neuropsychobiology, 2001. 43: p. 170-174. 342. Rothschild A. Olanzapine Response in Psychotic Depression. J Clin Psychiatry, 1999. 60: p. 2. 343. Rothschild A. How Long Should Patients With Psychotic Depression Stay on the Antipsychotic Medication? J Clin Psychiatry 2003. 64: p. 390-396. 344. Birkenhager T, W.R.J., Pliujms E. One year Follow up After Successful ECT: A naturalistic Study in Depressed Inpatient. J Clin Psychiatry, 2004. 65: p. 1. 345. Rapaport MH y Thase ME. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry, 2007. 68(4): p. e11. 346. Borges LE, et al. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception, 2006. 74(6): p. 446-50. 347. Steiner M, et al. Luteal Phase Administration of Paroxetine for the Treatment of Premenstrual Dysphoric Disorder: A Randomized, Double-Blind, Placebo- Controlled Trial in Canadian Women. J Clin Psychiatry, 2008: p. e1-e8. 348. Kripke C. Drug treatments for patients with dysthymia. Am Fam Physician, 2004. 70(7): p. 1269-70. 349. Koran LM, Aboujaoude EN y Gamel NN. Duloxetine treatment of dysthymia and double depression: an open-label trial. J Clin Psychiatry, 2007. 68(5): p. 761-5. 350. Orr G, et al. An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia. J Nerv Ment Dis, 2008. 196(6): p. 496-500. 351. Randlov C, et al. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study. Phytomedicine, 2006. 13(4): p. 215-21. 352. Cipriani AM y Geddes JRM. Antidepressants for Bipolar Disorder. A Clinical Overview of Efficacy and Safety in Psychiatryc Times. 2008, CMPMedica. p. 7. El material publicado (trabajos, comentarios) en el Tratado de Actualización en Psiquiatría representa la opinión de sus autores y no refleja necesariamente la opinión de la dirección o de la editorial. La mención de productos o servicios en esta publicación no implica que el director o la editorial los aprueben o los recomienden, deslindando cualquier responsabilidad al respecto. Edición 25 // mayo de 2009 El Tratado de Actualización en Psiquiatría es propiedad de: Sciens S.R.L. Juan Francisco Seguí 3569 Piso 2, Departamento “C” - Ciudad Autónoma de Buenos Aires. Tel/Fax (5411) 48028775 - www.sciens.com.ar Registro de Propiedad Intelectual N° 687224 32 Dr. Juan Cristóbal Tenconi, Dra. Oriana Sullivan Machado, Dr. Federico Nicolás Pavlovsky

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015